NexMed, Inc. (NEXM), a developer of innovative products based on the company’s proprietary NexACT drug delivery technology, announced that Hem Pandya has been elected as the company’s Chief Operating Officer. Mr. Pandya will fill the company’s newly created position and report directly to Chief Executive Officer, Vivian Liu.
Mr. Pandya recently served as Chief Commercial Officer for Putney, Inc., a start-up veterinary pharmaceutical company. Previous to this position, Mr. Pandya served as Senior Vice President of Business Development and Strategic Alliances for Andrx Pharmaceuticals, Inc., where he was in charge of licensing and co-development opportunities with various partners.
Ms. Liu, CEO of NexMed, stated “We are very pleased to welcome Hem to NexMed’s executive team. With over 12 years of pharmaceutical industry experience in the areas of business development, alliance management, strategic planning, and commercial operations, Hem brings a wide spectrum of operational and business development experience and strong leadership skills. Together we will shape the Company’s longer range business strategies.”
Let us hear your thoughts: